KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$2.6 million.

  • Biolife Solutions' Cash from Financing Activities fell 14572.53% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.5 million, marking a year-over-year decrease of 27516.8%. This contributed to the annual value of -$6.8 million for FY2024, which is 16404.49% down from last year.
  • Latest data reveals that Biolife Solutions reported Cash from Financing Activities of -$2.6 million as of Q3 2025, which was down 14572.53% from -$2.9 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Cash from Financing Activities peaked at $17.4 million during Q3 2022, and registered a low of -$4.1 million during Q4 2024.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$704000.0 (2024), whereas its average is $469368.4.
  • As far as peak fluctuations go, Biolife Solutions' Cash from Financing Activities soared by 174565.22% in 2022, and later tumbled by 30880.68% in 2025.
  • Biolife Solutions' Cash from Financing Activities (Quarter) stood at -$2.1 million in 2021, then skyrocketed by 70.31% to -$625000.0 in 2022, then soared by 1674.56% to $9.8 million in 2023, then plummeted by 141.52% to -$4.1 million in 2024, then soared by 37.4% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q3 2025, -$2.9 million for Q2 2025, and -$3.0 million during Q1 2025.